Editas Medicine Announces Fourth Quarter and Full Year 2021 Results and Business Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Editas Medicine Announces Fourth Quarter and Full Year 2021 Results and Business Updates

Editas Medicine (EDIT) Tops Q4 EPS by 11c

February 24, 2022 6:40 AM EST

Editas Medicine (NASDAQ: EDIT) reported Q4 EPS of ($0.61), $0.11 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $12.5 million versus the consensus estimate of $4.29 million.

For earnings history and earnings-related data on Editas Medicine (EDIT) click here.

... More